Conference Overview
Why Attend?
JSMO 2025 is one of the largest clinical oncology conferences in Asia. At JSMO 2024, we welcomed over 7,000 participants from 35 countries and regions, with 1,258 abstracts submitted. 74% of the presentations were conducted in English, making the conference truly international and enhancing interaction with global participants.
| Congress Name |
2025 the Japanese Society of Medical Oncology Annual Meeting |
|---|---|
| Theme | Precision Oncology Toward Practical Value for Patients |
| President | Tetsuji Takayama M.D.,ph.D Professor, Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences |
| Dates | Onsite & Live-Streaming: March 6–8, 2025 On-demand Streaming: March 6 – April 30, 2025 |
| A Hybrid Conference | JSMO2025 will be a hybrid event, held in-person in Kobe, Japan with some sessions available via live streaming and on-demand viewing as well. |
| Venue | Kobe Convention Center |
| Number of Expected Participants |
7,000 |
| Secretary | Department of Gastroenterology and Oncology, Tokushima University Graduate School of Biomedical Sciences 3-18-15, Kuramoto-cho, Tokushima, 770-8503, JAPAN |
| Congress Secretariat |
Japan Convention Services, Inc. Daido Seimei Kasumigaseki Bldg. 1-4-2, Kasumigaseki, Chiyoda-ku, Tokyo, 100-0013 Japan Email: jsmo2025[A]convention[D]co[D]jp ( Please change [A] to @ and [D] to . ) |
JSMO 2024 Numbers
- Total Attendees: 7,000+
- International Attendees: About 700
- Submitted Abstracts: 1,260
- English Presentations: 1,012 out of 1,369
- Attendees’ Country and Region: Japan + 35
JSMO2024 Top 17 Countries in Attendance
And there were participants from Australia, Iran, Mongolia, Myanmar, Macao, South Africa, Canada, Denmark, Gambia, Ghana, Italy, Kazakhstan, Mexico, Netherlands, Pakistan, Poland, Spain, Ukraine, too!
Abstract Topics and Numbers at JSMO 2024
| Topic | Number of Submitted Abstracts |
|---|---|
| Gastroenterology | 183 |
| Respiratory System | 143 |
| Case Reports (including Gene Panels) | 131 |
| Breast | 100 |
| Hepatobiliary and Pancreatic | 84 |
| Translational Research & Clinical Pharmacology | 75 |
| Rare Cancers & Cancer of Unknown Primary | 72 |
| Hematology | 71 |
| Palliative Care & Supportive Therapy | 60 |
| Urology | 54 |
| Cross-Organ Program | 53 |
| Head and Neck | 52 |
| Multidisciplinary Collaboration Program | 44 |
| Patient Support & Survivorship | 37 |
| Gynecology | 33 |
| Others | 28 |
| Clinical Trials Promotion Program | 24 |
| Artificial Intelligence (AI) | 16 |
